Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol.

A region along chromosome 7q was recently linked to components of the metabolic syndrome (MetS) in several genome-wide linkage studies. Within this region, the CD36 gene, which encodes a membrane receptor for long-chain fatty acids and lipoproteins, is a potentially important candidate. CD36 has been documented to play an important role in fatty acid metabolism in vivo and subsequently may be involved in the etiology of the MetS. The protein also impacts survival to malaria and the influence of natural selection has resulted in high CD36 genetic variability in populations of African descent. We evaluated 36 tag SNPs across CD36 in the HyperGen population sample of 2020 African-Americans for impact on the MetS and its quantitative traits. Five SNPs associated with increased odds for the MetS [P = 0.0027-0.03, odds ratio (OR) = 1.3-1.4]. Coding SNP, rs3211938, previously shown to influence malaria susceptibility, is documented to result in CD36 deficiency in a homozygous subject. This SNP conferred protection against the MetS (P = 0.0012, OR = 0.61, 95%CI: 0.46-0.82), increased high-density lipoprotein cholesterol, HDL-C (P = 0.00018) and decreased triglycerides (P = 0.0059). Fifteen additional SNPs associated with HDL-C (P = 0.0028-0.044). We conclude that CD36 variants may impact MetS pathophysiology and HDL metabolism, both predictors of the risk of heart disease and type 2 diabetes.

[1]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[2]  U. Seedorf,et al.  Emerging roles of PPARδ in metabolism , 2007 .

[3]  M. Roden.  Blocking fatty acids' mystery tour: a therapy for metabolic syndrome? , 2007, Cell Metabolism.

[4]  David Reich,et al.  Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants. , 2007, American journal of human genetics.

[5]  Xianlin Han,et al.  CD36 Is Important for Fatty Acid and Cholesterol Uptake by the Proximal but Not Distal Intestine* , 2007, Journal of Biological Chemistry.

[6]  T. Kurtz,et al.  Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies. , 2007, Hypertension.

[7]  Kylie J. Ralston,et al.  CD36 is a receptor for oxidized high density lipoprotein: Implications for the development of atherosclerosis , 2007, FEBS letters.

[8]  C. Rotimi,et al.  Meta-Analysis of Genome-Wide Linkage Studies of Quantitative Lipid Traits in Families Ascertained for Type 2 Diabetes , 2007, Diabetes.

[9]  D. Corella,et al.  Nutrient-gene interactions in lipoprotein metabolism - an overview. , 2007, Forum of nutrition.

[10]  P. Tso,et al.  CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. , 2006, Gastroenterology.

[11]  E. Feskens,et al.  Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[12]  Chia-Hung Liu,et al.  FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization , 2006, Nucleic Acids Res..

[13]  Pardis C Sabeti,et al.  Positive Natural Selection in the Human Lineage , 2006, Science.

[14]  J. Jukema,et al.  Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels , 2006, Clinical genetics.

[15]  Bradley M. Hemminger,et al.  TAMAL: an integrated approach to choosing SNPs for genetic studies of human complex traits , 2006, Bioinform..

[16]  S. Yamashita,et al.  Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients , 2007, Molecular and Cellular Biochemistry.

[17]  J. Odeberg,et al.  Alternative promoter usage of the membrane glycoprotein CD36 , 2006, BMC Molecular Biology.

[18]  H. Ginsberg,et al.  Regulation of plasma triglycerides in insulin resistance and diabetes. , 2005, Archives of medical research.

[19]  E. Boerwinkle,et al.  Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. , 2005, Diabetes.

[20]  J. Walters.  Recent findings in the cell and molecular biology of the small intestine , 2005, Current opinion in gastroenterology.

[21]  J. Pankow,et al.  An evaluation of the metabolic syndrome in the HyperGEN study , 2005, Nutrition & metabolism.

[22]  C. Dina,et al.  Genetic study of the CD36 gene in a French diabetic population. , 2004, Diabetes & metabolism.

[23]  A. Avogaro,et al.  A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. , 2004, Human molecular genetics.

[24]  Nathan D. Wong,et al.  Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.

[25]  G. Muscat,et al.  RORalpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR. , 2004, The Journal of biological chemistry.

[26]  P. Froguel,et al.  A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes , 2004, Human mutation.

[27]  A. C. Nicholson,et al.  CD36, oxidized LDL and PPARγ: pathological interactions in macrophages and atherosclerosis , 2004 .

[28]  A. Gotto,et al.  Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. , 2004, Journal of the American College of Cardiology.

[29]  John D. Storey,et al.  Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach , 2004 .

[30]  A. C. Nicholson,et al.  CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. , 2004, Vascular pharmacology.

[31]  B. Teusink,et al.  CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300143-JLR200 , 2003, Journal of Lipid Research.

[32]  S. Yamashita,et al.  Pathophysiology of human genetic CD36 deficiency. , 2003, Trends in cardiovascular medicine.

[33]  M. Sampson,et al.  Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. , 2003, Atherosclerosis.

[34]  K. Tokunaga,et al.  CD36 polymorphism is associated with protection from cerebral malaria. , 2003, American journal of human genetics.

[35]  T. Nakata,et al.  Insulin sensitivity and lipid metabolism in human CD36 deficiency. , 2003, Diabetes care.

[36]  Ronald Klein,et al.  Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. , 2002, Diabetes care.

[37]  A. Bonen,et al.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. , 2002, The Journal of clinical investigation.

[38]  P. O'Connell,et al.  Factors of insulin resistance syndrome--related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic mexican-americans. , 2002, Diabetes.

[39]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[40]  N. Abumrad,et al.  Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. , 2002, Annual review of nutrition.

[41]  H. Coon,et al.  Genome-Wide Linkage Analysis of Lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[42]  T. Nakata,et al.  Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. , 2001, Journal of lipid research.

[43]  William Arbuthnot Sir Lane,et al.  CD36 associates with CD9 and integrins on human blood platelets. , 2001, Blood.

[44]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[45]  R. Silverstein,et al.  Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice* , 2000, The Journal of Biological Chemistry.

[46]  M A Province,et al.  NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network. , 2000, Annals of epidemiology.

[47]  P. O'Connell,et al.  A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. , 2000, American journal of human genetics.

[48]  R. Silverstein,et al.  A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.

[49]  Seth M. Klein,et al.  Comparison of Class B Scavenger Receptors, CD36 and Scavenger Receptor BI (SR-BI), Shows That Both Receptors Mediate High Density Lipoprotein-Cholesteryl Ester Selective Uptake but SR-BI Exhibits a Unique Enhancement of Cholesteryl Ester Uptake* , 1999, The Journal of Biological Chemistry.

[50]  James Scott,et al.  Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats , 1999, Nature Genetics.

[51]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[52]  D. Gómez-Coronado,et al.  Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. , 1998, Journal of lipid research.

[53]  R. Aster,et al.  Incidence of the Nak(a)‐negative platelet phenotype in African Americans is similar to that of Asians , 1996, Transfusion.